Q-Med

Uppsala, Sweden Founded: 1987 • Age: 39 yrs Acquired By Galderma
Medical implants based on Non-Animal Stabilized Hyaluronic Acid for esthetics, orthopedics, urogynecology, and cell therapy.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Q-Med

Q-Med is a company based in Uppsala (Sweden) founded in 1987 by Manuel Aguero was acquired by Galderma in December 2011. Q-Med operates in a competitive market with competitors including Avita Medical, Suneva Medical, LifeCell, MoMelan Technologies and Quality by Design, among others.

  • Headquarter Uppsala, Sweden
  • Founders Manuel Aguero
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Galderma

    (Dec 13, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Q-Med

Premium access

Detailed funding history for Q-Med

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Q-Med

Q-Med has secured backing from 1 investor. Prominent investors backing the company include Galderma.

All
Investor Description Founded Year Domain Location
Dermatological products are manufactured to treat various skin conditions.
Locked Locked Locked
Premium access

Investor details for Q-Med

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Q-Med

Investments
Premium access

Investment portfolio details for Q-Med

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Q-Med

Premium access

Detailed financials for Q-Med

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Q-Med Comparisons

Q-Med Primary company
Description
Medical implants based on Non-Animal Stabilized Hyaluronic A...
Location
Uppsala, Sweden
Founded Year
1987
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Q-Med

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Q-Med

Q-Med operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avita Medical, Suneva Medical, LifeCell, MoMelan Technologies and Quality by Design, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Products for regenerative and respiratory medicine are developed and distributed.
Locked Locked Locked
Novel aesthetic products for regenerative markets are developed and commercialized.
Locked Locked Locked
Tissue repair products for regenerative medicine are developed and marketed.
Locked Locked Locked
Skin grafting technology for dermatological diseases and wound care
Locked Locked Locked
Medical grade collagen components are developed and manufactured.
Locked Locked Locked
Replica of human eye and Scar filler to fill skin defects
Premium access

Detailed competitors of Q-Med

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Q-Med

Premium access

Complete news archive for Q-Med

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Q-Med

Q-Med was founded in 1987.

Q-Med is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.

Q-Med engages in the development, manufacture, marketing, and sale of medical implants for aesthetic and medical use. The companys products are based on its patented technology, NASHA, which is used to produce stabilized non-animal hyaluronic acid. Its products include (1) Restylane products for filling out wrinkles and contouring lips (2) Macrolane VRF for body shaping (3) Deflux, which is used in the treatment of vesicoureteral reflux in children (4) Durolane for the treatment of osteoarthritis of the knee and hip joints (5) Solesta for the treatment of fecal incontinence. Q-Med sells its products through subsidiaries or distributors worldwide. In 2007 Q-Med acquired Ox-thera for approximately 30M. Q-Med was acquired by Galderma for 1.8B in 2011.

Q-Med's top competitors include Avita Medical, Quality by Design and Suneva Medical.

Q-Med has 1 investor. Key investors include Galderma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available